Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)

Clinical trial NCT05402332 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05402332
Sponsor: Eva Morava-Kozicz
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation

Start date: 2026-10-01
Primary completion: 2028-03-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.